Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Enlicitide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants Priority Vouchers to Merck's Drugs
    FDA Grants Priority Vouchers to Merck's Drugs

    20 Dec 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-grants-priority-vouchers-mercks-cholesterol-pill-cancer-therapy-2025-12-19/

    REUTERS
    20 Dec 2025
    Share Share
    Merck's Enlicitide Decanoate Reduces LDL-C In HeFH Adults
    Merck's Enlicitide Decanoate Reduces LDL-C In HeFH Adults

    09 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251109011682/en/Mercks-Enlicitide-Decanoate-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Adults-with-Heterozygous-Familial-Hypercholesterolemia-HeFH-in-Phase-3-CORALreef-HeFH-Trial

    BUSINESSWIRE
    09 Nov 2025
    Share Share
    Merck Enlicitide Decanoate Lowers LDL-C In Ph3 CORALreef Trial
    Merck Enlicitide Decanoate Lowers LDL-C In Ph3 CORALreef Trial

    08 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251108607082/en/Mercks-Enlicitide-Decanoate-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Phase-3-CORALreef-Lipids-Trial

    BUSINESSWIRE
    08 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.